Polar Asset Management Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-213,296
Closed -$2.14M 1204
2022
Q4
$2.14M Buy
213,296
+13,296
+7% +$132K 0.03% 615
2022
Q3
$1.96M Hold
200,000
0.02% 700
2022
Q2
$1.96M Hold
200,000
0.02% 706
2022
Q1
$1.95M Hold
200,000
0.02% 644
2021
Q4
$1.95M Hold
200,000
0.02% 611
2021
Q3
$1.94M Hold
200,000
0.02% 576
2021
Q2
$1.95M Buy
+200,000
New +$1.96M 0.02% 564

Other funds holding AONC

Polar Asset Management Partners's AONC Position: Q1 2023 in Review

Polar Asset Management Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 213,296 shares — an estimated $2.14M sold.

Polar Asset Management Partners first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $2.14M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Polar Asset Management Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 213,296 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $2.14M.
  • Polar Asset Management Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Polar Asset Management Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $2.14M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.